Age at Diagnosis Shapes the Prognosis of Childhood Immune Thrombocytopenia
ABSTRACT Objective Childhood immune thrombocytopenia (ITP), an acquired bleeding disorder, occurs at any age. Studies have indicated a less favourable prognosis in children aged above ten years. Low lymphocyte counts have been proposed as predictors of chronic disease. Detailed knowledge of ITP disease characteristics and prognosis at various ages may be useful to support clinical decision-making. We aimed to define how age shapes the clinical characteristics, biological parameters and disease outcomes in childhood ITP.Design Post-hoc analysis of two prospective European studies (NOPHO ITP study and TIKI trial). Children were followed for 6-12 months.Setting Patient inclusion in paediatrics departments in the Netherlands and the five Nordic countries.Patients Children aged <16 years with newly diagnosed ITP (N=577) and severe thrombocytopenia (diagnosis platelet count ≤20 × 109/L).Results By analysing age effects on a continuous scale, we observed that recovery rates at 3-12 months follow-up were gradually reduced in children aged above five years. An absence of a response to IVIg was observed at all ages, but was more common in older children, in particular above 6 years of age. Leukocyte and lymphocyte subset counts were reduced with age, but not elevated or decreased compared to age-appropriate reference intervals. Children aged below seven years showed elevated thrombopoietin levels.Conclusions Already from five years of age onwards, there is an increasing risk for a long-lasting course of ITP. Given the varying treatment responses and biological variation, age differences should be considered for the design of clinical trials, prediction models and biological studies..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 28. Okt. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schmidt, David E. [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.06.09.20125385 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI018123929 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI018123929 | ||
| 003 | DE-627 | ||
| 005 | 20230429100931.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200615s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.06.09.20125385 |2 doi | |
| 035 | |a (DE-627)XBI018123929 | ||
| 035 | |a (biorXiv)10.1101/2020.06.09.20125385 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schmidt, David E. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Age at Diagnosis Shapes the Prognosis of Childhood Immune Thrombocytopenia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Objective Childhood immune thrombocytopenia (ITP), an acquired bleeding disorder, occurs at any age. Studies have indicated a less favourable prognosis in children aged above ten years. Low lymphocyte counts have been proposed as predictors of chronic disease. Detailed knowledge of ITP disease characteristics and prognosis at various ages may be useful to support clinical decision-making. We aimed to define how age shapes the clinical characteristics, biological parameters and disease outcomes in childhood ITP.Design Post-hoc analysis of two prospective European studies (NOPHO ITP study and TIKI trial). Children were followed for 6-12 months.Setting Patient inclusion in paediatrics departments in the Netherlands and the five Nordic countries.Patients Children aged <16 years with newly diagnosed ITP (N=577) and severe thrombocytopenia (diagnosis platelet count ≤20 × 109/L).Results By analysing age effects on a continuous scale, we observed that recovery rates at 3-12 months follow-up were gradually reduced in children aged above five years. An absence of a response to IVIg was observed at all ages, but was more common in older children, in particular above 6 years of age. Leukocyte and lymphocyte subset counts were reduced with age, but not elevated or decreased compared to age-appropriate reference intervals. Children aged below seven years showed elevated thrombopoietin levels.Conclusions Already from five years of age onwards, there is an increasing risk for a long-lasting course of ITP. Given the varying treatment responses and biological variation, age differences should be considered for the design of clinical trials, prediction models and biological studies. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Edslev, Pernille Wendtland |e verfasserin |4 aut | |
| 700 | 1 | |a Heitink-Pollé, Katja M.J. |e verfasserin |4 aut | |
| 700 | 1 | |a Kapur, Rick |e verfasserin |4 aut | |
| 700 | 1 | |a Porcelijn, Leendert |e verfasserin |4 aut | |
| 700 | 1 | |a van der Schoot, C. Ellen |e verfasserin |4 aut | |
| 700 | 1 | |a Vidarsson, Gestur |e verfasserin |4 aut | |
| 700 | 1 | |a Bruin, Marrie C.A. |e verfasserin |4 aut | |
| 700 | 1 | |a Rosthøj, Steen |e verfasserin |4 aut | |
| 700 | 1 | |a de Haas, Masja |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 28. Okt. |
| 773 | 1 | 8 | |g year:2022 |g day:28 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.06.09.20125385 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 28 |c 10 | ||